Lava Therapeutics Nv's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lava Therapeutics Nv's ROI in the third quarter of 2025?
Lava Therapeutics Nv recorded a cumulative net loss of $-23 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -41.74%.

Within the Healthcare sector Lava Therapeutics Nv achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the second quarter of 2025 at no. .

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Investment Change TTM	-17.41 %	9.06 %	108.36 %	4218.98 %	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	48	55	52	68	57
Return On Investment (TTM)	-41.74 %	-48.98 %	-42.64 %	-30.52 %	-31.58 %
LVTX's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-3.97 %	-11.88 %	-20.26 %	22.39 %	26.81 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-23	-28	-28	-25	-21

LVTX Company Profile >> Back to LVTX Roi Comparisons >> See Annual LVTX Return On Investment

Return On Investment LVTX's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Lava Therapeutics Nv's III. Quarter Investments	$ 48 Millions	LVTX's Balance sheet
Lava Therapeutics Nv's III. Quarter Income	$ -7 Millions	Quarterly LVTX's Income Statement
LVTX's Income by Division		See LVTX's Income by Division

LVTX Annual Return On Investment	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2020) 2021
Total Investments in Millions	68	92	122	128	0
Y / Y Investment Growth	-26.63 %	-23.94 %	-5.04 %	-	-
Net Income in Millions	-25	-42	-32	-42	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-37.02 %	-45.29 %	-26.25 %	-33.09 %	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LVTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LVTX's Competitors
Subscribers only: Roi for Lava Therapeutics Nv's Suppliers
Subscribers only: Return On Investment for LVTX's Customers

Other Ratios
LVTX's Roa	LVTX's Inventory Turnover Ratio	LVTX's Growth Rates	LVTX's Dividend Statistics
	LVTX's Profitability Ratios	LVTX's Asset Turnover Ratio	LVTX's Dividend Growth
LVTX's Roe	LVTX's Valuation Ratios	LVTX's Financial Strength Ratios	LVTX's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:43:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.